MEET QPS AT THE WORLDSymposium™ 2024; February 4 - 9, SAN DIEGO, CALIFORNIA, USA

Corner Turn Test

Corner Turn Test

The corner turn test is frequently used to evaluate sensorimotor impairments due to unilateral or asymmetric striatal damage. It allows quantification of the turning preference (left or right) upon approaching a corner. Animals with striatal lesion typically exhibit a turning asymmetry that is correlated to the extent of striatal injury. While healthy animals usually show an approximately equal number of right and left turns, impaired animals preferentially turn to the side that is ipsilateral to the lesion.

The corner test device consists of two walls with an opening on one side and a 30° angle on the other side. The open side is placed on the edge of the table, permitting exploration only towards the corner but not outside the device. After the animal approaches the narrow corner, it rears forward and upward, then turns back to face the open end. A total of 10 consecutive trials with approximately 30 seconds resting time in between are performed. The side to which the animal turns is recorded for each trial. Turning movements that are not part of a rearing movement are not scored.

There are several advantages of the corner turn test. First, it is simple to perform as it does not require pretraining. Next, there is no need for external re-enforcement of the exploratory behavior since rodents are curious by nature, allowing the assessment in a natural setting. Additionally, training does not affect performance which enables repeated testing of the same animals offering an advantage for substance testing in chronic disease models, such as Parkinson’s disease. Since this test is sensitive to asymmetric striatal damage, it is valuable in unilateral lesion models, e.g., the 6-OHDA model. In addition to the corner turn test, the cylinder testcorridor testrotation test, and pasta gnawing test are helpful tools to evaluate unilateral striatal lesions.

Corner-Turn-TestChart
Corner-Turn-Test

Corner turn test 1 to 5 weeks after 6-OHDA or sham lesion in rats. Sham: n = 16, 6-OHDA: n=31. Two-way ANOVA followed by Bonferroni’s post hoc test; mean ± SEM; ***p<0.001.

In Vitro Services

QPS Neuropharmacology provides research services with numerous standardized cell culture systems including transgenic and non-transgenic cell lines, glial cells, primary chicken and rat peripheral and central nervous system neurons of different developmental stages and organotypic brain slices. New models are developed and validated on request.
LEARN MORE

In Vivo Services

As a leading CRO for CNS drug development, QPS Neuropharmacology is the premier provider for services with transgenic animals. We have more than 20 years of experience in generating, characterizing, and maintaining transgenic disease models and applying them for drug testing projects.
LEARN MORE

Ex Vivo Services

QPS Neuropharmacology's expertise lies within the field of neurodegenerative diseases. We provide a state of the art research environment (AAALAC certified) for testing and evaluating new potential treatment approaches.
LEARN MORE

Biobank

QPS Neuropharmacology's well characterized and validated in vivo models are useful tools to push your CNS drug discovery research forward. We are happy to support your research activities with sample material from our biobank composed of various specimen derived from our in-house in vivo models.
LEARN MORE

animal models

QPS Neuropharmacology is highly experienced in generating, characterizing, and maintaining transgenic disease models and using them for drug testing projects for more than 20 years.
LEARN MORE

behavioral testing

QPS Neuropharmacology provides a wide range of behavioral tests for various indications. Most tests are evaluated using rater-independent digital animal tracking systems.
LEARN MORE

histology services

QPS Neuropharmacology offers a full set of histology services ranging from collection of tissue samples to delivering study reports that contain all experimental procedures and their outcome.
LEARN MORE

biomarkers

QPS Neuropharmacology Department of Translational Medicine offers a selection of molecular biological methods for the investigation of various diseases. The unit supports in vitro and in vivo studies performed at QPS Austria.
LEARN MORE